Maternal care continues to face significant challenges as healthcare systems struggle with fragmented care pathways, limited clinical resources, and outdated monitoring models that can leave high-risk pregnancies without sufficient surveillance. While complications such as gestational diabetes, preeclampsia, placental complications, and preterm birth require timely detection and intervention, many patients still lack access to continuous insights into their health and the health of their babies.

Bloomlife was founded in 2014 by Eric Dy and Julien Penders after Eric Dy’s wife experienced a high-risk pregnancy involving placental complications, gestational diabetes, preeclampsia, and preterm birth, which resulted in their son spending his first month of life in the neonatal intensive care unit (NICU). Experiencing these challenges firsthand, the founders set out to transform how maternal care is delivered.

Today, Bloomlife is a maternal health technology company developing connected care solutions that enable healthcare providers to monitor pregnancy health remotely, improve clinical decision-making, and enhance birth outcomes. Through its proprietary maternal-fetal monitor, third-party devices, and clinical data, the company is developing digital biomarkers, risk stratification solutions, and data-driven tools to support earlier identification of potential complications.

Remote Monitoring for Better Maternal Care

Bloomlife provides a comprehensive remote patient monitoring (RPM) program designed to help healthcare teams assess maternal and fetal health beyond traditional clinic visits. The platform enables providers to monitor high-risk pregnancies remotely while improving access to timely health information, reducing care gaps, and supporting faster clinical decisions.

Bloomlife’s RPM solutions support the management of key maternal health conditions, including diabetes and hypertension, by enabling patients to monitor important health indicators from home. Through connected devices, including glucose monitors, blood pressure cuffs, and maternal-fetal monitoring technology, patients can collect and share health data with their care teams while receiving guidance on recommended next steps.

The platform helps healthcare providers move away from fragmented monitoring methods by providing a centralized view of patient data through a clinical dashboard. Customizable notifications and escalation workflows allow care teams to identify patients requiring attention, coordinate care efficiently, and focus resources on those needing in-person support.

Bloomlife’s remote monitoring approach improves patient engagement, adherence, and outcomes by enabling more consistent data collection compared with traditional paper-based monitoring methods. The platform helps healthcare teams better manage conditions associated with high-risk pregnancies while reducing administrative workload and adapting to existing clinical workflows.

In addition to diabetes and hypertension monitoring, Bloomlife is developing fetal monitoring capabilities designed to expand access to antepartum fetal surveillance. The investigational fetal monitoring device, which is FDA-cleared for maternal and fetal heart rate monitoring and pending clearance for uterine activity and full non-stress test (NST) indications, is designed to help clinicians track fetal well-being while reducing the need for frequent clinic visits.

Bloomlife Connects

Bloomlife Connects enables healthcare providers to manage high-risk pregnancies outside traditional office visits while reducing administrative workload and improving care coordination. The platform provides clinicians with reliable patient data before appointments, helping them identify potential concerns earlier and make informed clinical decisions.

Designed to integrate with existing workflows and electronic medical records (EMRs), Bloomlife Connects allows care teams to customize data access, notification settings, and review processes based on their operational needs. By automating data collection and reducing reliance on manual logs, the platform helps providers spend less time managing administrative tasks and more time delivering effective patient care.

Clinical research has shown that remote monitoring can improve maternal health management by increasing adherence to monitoring protocols, supporting better blood pressure and glucose management, and reducing risks associated with pregnancy complications. Through Bloomlife Connects, healthcare teams can deliver more proactive and efficient maternity care.

ERIC DY | CO-FOUNDER & CEO

Eric Dy, co-founder, is the CEO of Bloomlife, where he leads the company’s efforts to transform maternal care delivery through wearable technology, remote monitoring, and data-driven healthcare solutions. With a background in biomedical engineering and healthcare innovation, he focuses on developing technologies that help healthcare providers gain deeper insights into maternal and fetal health.

Before founding Bloomlife with Julien Penders in 2014, Eric worked at imec, where he contributed to healthcare technology development and business initiatives. He holds a Bachelor of Science degree in Bioengineering from Cornell University and a Ph.D. in Biomedical Engineering from the University of California, Los Angeles (UCLA).

Through his leadership at Bloomlife, Eric is focused on addressing challenges in maternal care by developing solutions that provide healthcare teams with continuous health insights, support earlier identification of potential complications, and improve outcomes for mothers and babies.